The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia

European Journal of Haematology

Volumn 79, Issue 1, 2007, Pages 47-52

  Van Der Velden, Ankie M T ^a,b   Van Velzen Blad, Heleen ^b   Claessen, Anke M E ^b   Van Der Griend, René ^c   Oltmans, Ruud ^d   Rijkers, Ger T ^b,e   Biesma, Douwe H ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d Mesos Medical Centre   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Chronic lymphocytic leukaemia; Haemophilus influenza type b; Ranitidine; Streptococcus pneumoniae; Vaccination

Indexed keywords

ACT HIB; ANTIBODY; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HAEMOPHILUS INFLUENZAE TYPE B ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; PNEUMOCOCCAL POLYSACCHARIDE ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; RANITIDINE; RANTES; TETANUS TOXOID; TETANUS TOXOID ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ANTIBODY RESPONSE; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLUENZA; MALE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; TETANUS; UNSPECIFIED SIDE EFFECT; VACCINATION;

AGED; ANTIBODY FORMATION; CASE-CONTROL STUDIES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; RANITIDINE;

EID: 34347230163     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00862.x     Document Type: Article

References (32)

1. Keating MJ. Chronic lymphocytic leukaemia. Semin Oncol 1999 26 : 107 14.
2. Griffiths H, Lea J, Bunch C, Lee M, Chapel H. Predictors of infection in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol 1992 89 : 374 7.
3. Gowda R, Razvi FM, Summerfield GP. Risk of pneumococcal septicaemia in patients with chronic lymphoproliferative malignancies. BMJ 1995 311 : 26 7.
4. Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981 3 : S184 S96.
5. Rubins JB, Puri AKG, Loch J, Charboneau D, MacDonald R, Opstad N, et al. Magnitude, duration, quality and function of pneumococcal vaccine responses in elderly adults. J Infect Dis 1998 178 : 431 40.
6. Gardner P, Schaffner W. Immunization of adults. N Engl J Med 1993 328 : 1252 8.
7. Sinisalo M, Aittoniemi J, Oivanen P, Käyhty H, Ölander RM, Vilpo J. Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia. Br J Haematol 2001 114 : 107 10.
8. Hartkamp A, Mulder AHL, Rijkers GT, van Velzen-Blad H, Biesma DH. Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine 2001 19 : 1671 7.
9. Mellemgaard A, de Nully Brown P, Heron I, Geisler CH, Hansen MM, Moesgaard F, et al. Ranitidine improves the vaccination response in patients with chronic lymphocytic leukaemia-a randomized, controlled study. Immunol Inf Dis 1993 3 : 109 11.
10. Jurlander J, de Nully Brown P, Skov PS, Henrichsen J, Heron I, Obel N, et al. Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukaemia. Leukemia 1995 9 : 1902 9.
11. Jutel M, Watanabe T, Akdis M, Blaser K, Akdis CA. Immune regulation by histamine - opinion. Curr Opin Immunol 2002 14 : 735 40.
12. Rai KR, Sawitsky A, Cronkite EP, Chand AD, Levy RN, Pasternak BS. Clinical staging of chronic lymphocytic leukaemia. Blood 1975 46 : 219 34.
13. Goldblatt D, Levinsky RJ, Turner MW. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood. J Infect Dis 1992 166 : 632 4.
14. Herrmann DJ, Hamilton RG, Barington T, Frasch CE, Arakere G, Makela O, et al. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods 1992 148 : 101 14.
15. Käthy H, Peltola H, Karanko V, Mäkelä P. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983 147 : 1100 3.
16. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001 20 : 63 75.
17. World Health Organization. Pneumococcal conjugate vaccines. Recommendations for the production and control of pneumococcal conjugate vaccines. World Health Organ Tech Rep Ser 2005 927 : 64 98.
18. De Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003 10 : 133 9.
19. Kohka H, Nishibori M, Iwagaki H, Nakaya N, Yoshino T, Kobashi K, et al. Histamine is a potent inducer of IL-18 and IFN-γ in human peripheral blood mononuclear cells. J Immunol 2000 164 : 6640 6.
20. Lippert U, Moller A, Welker P, Artuc M, Henz BM. Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol 2000 9 : 118 24.
21. Falus A, Merétey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 1992 13 : 154 6.
22. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OAR, Malolepszy J, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001 413 : 420 4.
23. Yamashita M, Fukui H, Sugama K, Horio Y, Ito S, Mizuguchi H, et al. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc Natl Acad Sci USA 1991 88 : 11515 9.
24. Gantz I, DelValle J, Wang LD, Tashiro T, Munzert G, Guo YJ, et al. Molecular basis for the interaction of histamine with the histamine H2 receptor. J Biol Chem 1992 267 : 20840 3.
25. Lovenberg TW, Roland BL, Wilson SJ, Jinag X, Pyati J, Huvar A, et al. Cloning and expression of the human histamine H3 receptor. Mol Pharmacol 1999 55 : 1101 7.
26. Nakamura T, Itadani H, Hidaka Y, Ohta M, Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 2000 279 : 615 20.
27. Beer DJ, Rocklin RE. Histamine modulation of lymphocyte biology: membrane receptors, signal transduction, and functions. Crit Rev Immunol 1987 7 : 55 91.
28. Plaut M, Marone G, Gillespie E. The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents. J Immunol 1983 131 : 2945 52.
29. Airoldi I, Raffaghello L, Cocco C, Guglielmino R, Roncella S, Fedeli F, et al. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naïve, germinal center and memory B lymphocytes. Clin Cancer Res 2004 10 : 144 54.
30. Hudson RP, Wilson SJ. Hypogammaglobulinemia and chronic lymphocytic leukaemia. Cancer 1960 13 : 200 4.
31. Kay NE. Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation. Blood 1981 57 : 418 20.
32. Chiorazzi N, Fu SM, Montazeri G, Kunkel HG, Rai K, Gee T. T cell helper defect in patients with chronic lymphocytic leukaemia. J Immunol 1979 122 : 1087 90.